Lonza Group

URI: https://gptkb.org/entity/Lonza_Group

GPTKB entity

Statements (62)

Predicate	Object
gptkbp:instance_of	gptkb:Company
gptkbp:acquisition	Capsugel (2017) Wacker Biotech (2020)
gptkbp:ceo	gptkb:Marc_Funk
gptkbp:employees	15,000 (2020)
gptkbp:focus	cell and gene therapy
gptkbp:founded	1897
gptkbp:headquarters	gptkb:Basel,_Switzerland
https://www.w3.org/2000/01/rdf-schema#label	Lonza Group
gptkbp:industry	gptkb:pharmaceuticals
gptkbp:location	gptkb:Switzerland
gptkbp:market_cap	approximately 20 billion CHF (2021)
gptkbp:partnership	gptkb:Eli_Lilly gptkb:GSK gptkb:Johnson_&_Johnson gptkb:Zymeworks gptkb:Amgen's_COVID-19_treatment gptkb:Astra_Zeneca's_COVID-19_vaccine gptkb:Bayer's_COVID-19_treatment gptkb:Eli_Lilly's_COVID-19_treatment gptkb:GSK's_COVID-19_vaccine gptkb:Janssen's_COVID-19_vaccine gptkb:Merck's_COVID-19_treatment gptkb:Moderna's_COVID-19_vaccine gptkb:Novavax's_COVID-19_vaccine gptkb:Pfizer's_COVID-19_vaccine gptkb:Regeneron's_COVID-19_treatment gptkb:Roche's_COVID-19_vaccine gptkb:Sanofi's_COVID-19_vaccine gptkb:Takeda's_COVID-19_treatment gptkb:Astra_Zeneca gptkb:Sanofi gptkb:Boehringer_Ingelheim gptkb:Bristol-Myers_Squibb gptkb:Pfizer gptkb:Moderna gptkb:Sangamo_Therapeutics gptkb:Merck_&_Co. gptkb:Roche gptkb:Bayer gptkb:Amgen gptkb:Vertex_Pharmaceuticals gptkb:Abb_Vie gptkb:Celgene gptkb:Regeneron gptkb:Novartis gptkb:Aimmune_Therapeutics gptkb:Takeda Abb Vie's COVID-19 treatment Boehringer Ingelheim's COVID-19 treatment
gptkbp:products	biopharmaceuticals
gptkbp:revenue	5.3 billion CHF (2020)
gptkbp:services	contract manufacturing
gptkbp:stock_exchange	gptkb:SIX_Swiss_Exchange
gptkbp:stock_symbol	LONN
gptkbp:subsidiary	gptkb:Lonza_Biologics
gptkbp:type	gptkb:public_company
gptkbp:website	www.lonza.com
gptkbp:bfsParent	gptkb:Swiss_Exchange gptkb:Moderna gptkb:Avantor,_Inc.
gptkbp:bfsLayer	5